Shreyas Hastantram Nagendrababu

Shreyas Hastantram Nagendrababu

Director Additional Director DIN 08227926
DIN 08227926 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jan 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreyas Hastantram Nagendrababu

Data last updated:

Shreyas Hastantram Nagendrababu was an Additional Director at Cadbel Pharmaceuticals Private Limited (2019). The company operates in Pharma.

DIN 08227926
Primary Designation Additional Director
Industry Pharma
First Appointment 16 Jan 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director16 Jan 20192016₹7.3 Lakh (FY 2018)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cadbel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shreyas Hastantram Nagendrababu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreyas Hastantram Nagendrababu

Shreyas Hastantram Nagendrababu was first appointed on 16 Jan 2019 as Additional Director at Cadbel Pharmaceuticals Private Limited.

Shreyas Hastantram Nagendrababu held 1 earlier board appointment: Cadbel Pharmaceuticals Private Limited (Additional Director, 16 Jan 2019 to 31 Oct 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available